Background. Although it is widely accepted that adults with immunocompromising
conditions are at greatly increased risk of pneumococcal infection, the extent of risk among …

Objective The aims of this study were to evaluate health outcomes and the economic burden
of hospitalized COVID-19 patients in the United States. Methods Hospitalized patients with …

We estimated the rate of reactivation tuberculosis (TB) in the United States, overall and by
population subgroup, using data on TB cases and Mycobacterium tuberculosis isolate …

Defining the propensity of Streptococcus pneumoniae (SP) serotypes to invade sterile body
sites following nasopharyngeal (NP) acquisition has the potential to inform about how much …

The universal immunization of infants and toddlers with pneumococcal conjugate vaccine (PCV)
in the United States beginning in 2000 heralded a new era for pneumococcal disease …

Background The presence of certain underlying medical conditions is known to increase the
risk of pneumococcal disease in persons of all ages and across a wide spectrum of …

Background The consequences of the ageing population concerning ICU hospitalisation need
to be adequately described. We believe that this discussion should be disease specific. A …

Children with previously identified at-risk/high-risk conditions remain at elevated risk of
pneumococcal disease in the era of widespread use of pneumococcal conjugate vaccine. …

Background: Heptavalent pneumococcal conjugate vaccine (PCV7) was licensed in the
United States in February 2000 and distributed in Massachusetts, starting in July 2000 for …

Although SARS-CoV-2, responsible for COVID-19, is primarily a respiratory infection, a broad
spectrum of cardiac, pulmonary, neurologic, and metabolic complications can occur. More …